Advertisement

AJNR Awards, New Junior Editors, and more. Read the latest AJNR updates

Index by author

March 01, 2013; Volume 34,Issue 3

  1. Horvath, K.A.

    1. EDITOR'S CHOICEBrain
      Open Access
      Blood-Brain Barrier Disruption after Cardiac Surgery
      J.G. Merino, L.L. Latour, A. Tso, K.Y. Lee, D.W. Kang, L.A. Davis, R.M. Lazar, K.A. Horvath, P.J. Corso and S. Warach
      American Journal of Neuroradiology March 2013, 34 (3) 518-523; DOI: https://doi.org/10.3174/ajnr.A3251

      To shed light on brain complications occurring after heart surgery, the authors assessed BBB disruption and DWI findings in half of their patients by imaging at 24 hours after surgery and 24–48 hours later. Additionally, postcontrast T1 images were obtained postoperatively at 2–4 days in the other half of the patients. Almost half the patients undergoing cardiac surgery had evidence of BBB abnormalities and three-quarters showed acute lesions on DWI after surgery. BBB disruption is more prevalent in the first 24 hours after surgery. These findings suggest that MR can be used as an imaging biomarker to assess therapies that may protect the BBB in patients undergoing heart surgery.

  2. Hou, G.-Q.

    1. Brain
      Open Access
      MR Imaging of Cerebral Extraventricular Neurocytoma: A Report of 9 Cases
      K. Liu, G. Wen, X.-F. Lv, Yan-Jia Deng, Yong-Jian Deng, G.-Q. Hou, X.-L. Zhang, L.-J. Han and J.-L. Ding
      American Journal of Neuroradiology March 2013, 34 (3) 541-546; DOI: https://doi.org/10.3174/ajnr.A3264

  3. Huang, Q.-H.

    1. Neurointervention
      Open Access
      Endovascular Reconstruction for Treatment of Vertebrobasilar Dolichoectasia: Long-Term Outcomes
      X. Wu, Y. Xu, B. Hong, W.-Y. Zhao, Q.-H. Huang and J.-M. Liu
      American Journal of Neuroradiology March 2013, 34 (3) 583-588; DOI: https://doi.org/10.3174/ajnr.A3248

  4. Hyman, B.T.

    1. EDITOR'S CHOICEBrain
      Open Access
      Apolipoprotein E ε4 Does Not Modulate Amyloid-β–Associated Neurodegeneration in Preclinical Alzheimer Disease
      R.S. Desikan, L.K. McEvoy, D. Holland, W.K. Thompson, J.B. Brewer, P.S. Aisen, O.A. Andreassen, B.T. Hyman, R.A. Sperling, A.M. Dale and for the Alzheimer's Disease Neuroimaging Initiative
      American Journal of Neuroradiology March 2013, 34 (3) 505-510; DOI: https://doi.org/10.3174/ajnr.A3267

      These authors investigated the relationship between amyloid-β, phosphorylated tau, and apolipoprotein E in preclinical Alzheimer disease in 170 patients and controls who had serial imaging up to 3.5 years after the initial study. Global volumes as well as volumes in brain regions known to be involved in the chronic stages of the disease were assessed. Their results led them to propose that atrophy rates are primarily influenced by apolipoprotein E via amyloid-β mechanisms and that amyloid-β -associated neurodegeneration occurs only in the presence of phosphorylated tau.

« Previous (Pages : 1 2 ... 2)next »
Back to top

In this issue

Advertisement
Advertisement